We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


FUJIFILM Irvine to be Worldwide Distributor of Chemical Substrate for Stem Cell Culture

FUJIFILM Irvine to be Worldwide Distributor of Chemical Substrate for Stem Cell Culture content piece image
Credit: FUJIFILM Irvine Scientific
Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

FUJIFILM Irvine Scientific, Inc., announced on the 29th September that it has become the exclusive, worldwide distributor of cellnest®, a recombinant peptide attachment substrate that provides optimal adhesion and proliferation of stem cells in chemically defined, animal component-free conditions. Cellnest was designed and manufactured by FUJIFILM Corporation, joining its vast portfolio of solutions that support life science applications and therapeutic innovation.

Attachment substrates mimic the extracellular matrix (ECM), a complex and dynamic environment in which cells reside in vivo, in cell culture and allow for the adhesion, expansion, and potential differentiation of stem cells. Unlike animal-derived components, which can introduce unpredictability in results, the chemically defined, animal component-free formula of cellnest provides consistent results to researchers, and can smooth the regulatory path to commercialization. Cellnest is compatible with any adherent cell type that binds to the Arg-Gly-Asp (RGD) domain, an amino acid sequence within the extracellular matrix protein fibronectin that mediates cell attachment. It is an ideal companion product to FUJIFILM Irvine Scientific’s PRIME-XV portfolio of xeno-free and chemically defined media for stem cell culture, and is well suited for the attachment and growth of mesenchymal stem cells (MSCs).

“We are dedicated to accelerating the development and introduction of new offerings, including cellnest, to support our partners in advancing cell and gene therapy research,” said Yutaka Yamaguchi, General Manager, Life Science Strategic Business Office, FUJIFILM Holdings America Corporation, and Chairman and CEO, FUJIFILM Irvine Scientific. “Leveraging the collective expertise and capabilities of our resources within the network of Fujifilm life science companies enables us to provide innovative solutions for our partners, from discovery through to commercialization.”